% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Beschorner:281845,
author = {Beschorner, Natalie and Xu, Ying and Jucker, Mathias and
Ruiz-Riquelme, Alejandro},
title = {{A}myloid‐β {S}eeds in {A}lzheimer's {D}isease:
{R}esearch {C}hallenges and {I}mplications},
journal = {Journal of neurochemistry},
volume = {169},
number = {11},
issn = {0022-3042},
address = {Oxford},
publisher = {Wiley-Blackwell},
reportid = {DZNE-2025-01224},
pages = {e70267},
year = {2025},
abstract = {The amyloid cascade hypothesis, proposed over 30 years
ago, places amyloid-β (Aβ) at the center of Alzheimer's
disease (AD) pathogenesis. Though controversial, recent
clinical successes with Aβ-targeting therapies have
reinforced its importance. However, these treatments have
shown only modest clinical benefits in line with a two-stage
AD progression: an early phase driven by Aβ-seed and a
later phase that progresses at least partly independently of
Aβ. Evidence of Aβ seed transmission in humans raises both
therapeutic potential and biosafety concerns. This review
explores current understanding of Aβ seeds, including
challenges in studying such seeds, model systems to study
Aβ seeds, and biosafety issues when working with Aβ
seeds.},
subtyp = {Review Article},
cin = {AG Petzold / AG Jucker},
ddc = {610},
cid = {I:(DE-2719)1013020 / I:(DE-2719)1210001},
pnm = {353 - Clinical and Health Care Research (POF4-353) / 352 -
Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-353 / G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
doi = {10.1111/jnc.70267},
url = {https://pub.dzne.de/record/281845},
}